Appropriate use and interpretation of serological tests for assessments of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, infection and potential immunity …

Appropriate use and interpretation of serological tests for assessments of SARS-CoV-2
exposure, infection and potential immunity require accurate assay performance data. We …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can
be detected indirectly by measuring the host immune response. For some viruses, antibody …

Given the limited availability of serological testing to date, the seroprevalence of SARS-CoV-2-specific
antibodies in different populations has remained unclear. Here, we report very …

Although coronavirus disease 2019 (COVID-19) causes cardiac dysfunction in up to 25% of
patients, its pathogenesis remains unclear. Exposure of human induced pluripotent stem cell …

Trypanosoma cruzi is the etiological agent of Chagas disease, usually transmitted by triatomine
vectors. An estimated 20 to 30% of infected individuals develop potentially lethal cardiac …

We combined American Community Survey data with age-specific Trypanosoma cruzi
prevalence derived from US surveys and World Health Organization reports to yield estimates of …

Although COVID-19 causes cardiac dysfunction in up to 25% of patients, its pathogenesis
remains unclear. Exposure of human iPSC-derived heart cells to SARS-CoV-2 revealed …

Patients with MLLr B-ALL have poor prognoses despite recent immunotherapy advances.
Here, surface proteomics identifies CD72 as being enriched on MLLr B-ALL but also widely …

Chagas disease affects an estimated 300,000 individuals in the United States. Diagnosis in
the chronic phase requires positive results from two different IgG serological tests. Three …